Galapagos Aktie - GXE

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

23,66

Gebot

23,56

Fragen

23,74

Volumen

444

23,26 Tagesbereich 23,60

20,20 52-Wochen-Bereich 30,96

Marktkapitalisierung

1,558B

Handelsende

23,12

Handelsbeginn

23,26

Letzte Trade

23.42

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

1.727

Ausgegebene Aktien

65.835.511

Dividendenrendite

Kurs-Gewinn-Verhältnis

20,79

Gewinn pro Aktie (EPS)

1,13

Erlöse

410,12M

Nettogewinn

74,08M

Sektor

Coml Physical, Biologcl Resh

Branche

Coml Physical, Biologcl Resh

Website

www.glpg.com

Hauptsitz

Mechelen, Antwerp, Bel

Gegründet

Galapagos is listed in the Coml Physical, Biologcl Resh sector of the Tradegate (DE) with ticker GXE. The last closing price for Galapagos was 23,12 €. Over the last year, Galapagos shares have traded in a share price range of 20,20 € to 30,96 €.

Galapagos currently has 65.835.511 shares in issue. The market capitalisation of Galapagos is 1,52 € billion. Galapagos has a price to earnings ratio (PE ratio) of 20.79.

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts First U.S. patient dosed in ATALANTA-1...

Galapagos Announces Executive Leadership Updates

Galapagos Announces Executive Leadership Updates Mr. Henry Gosebruch appointed by the Galapagos Board of Directors as founding CEO of newly...

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025 Mechelen, Belgium; April 15, 2025, 07:30 CET; regulated...

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting Mechelen, Belgium; March 27, 2025, 21:01 CET; regulated...

Galapagos to Present at Upcoming Investor Conferences

Galapagos to Present at Upcoming Investor Conferences Mechelen, Belgium; February 24, 2025, 22:01 CET – Galapagos NV (Euronext & NASDAQ:...

Galapagos receives transparency notification and 13D filing from Tang Capital

Galapagos receives transparency notification and 13D filing from Tang Capital Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated...

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update Compelling clinical results for GLPG5101 in three NHL...

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos intends to create a new...

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Mechelen, Belgium; January 7, 2025, 22:01 CET; Galapagos NV (Euronext...

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	1.9	8.73161764706	21.76	23.6	21.62	1097	22.59049818	DE
4	-0.08	-0.33698399326	23.74	23.74	20.2	2214	21.76392006	DE
12	1.26	5.625	22.4	26.22	20.2	1727	22.71075278	DE
26	-3.26	-12.1099554235	26.92	30.96	20.2	5016	24.80659999	DE
52	-3.16	-11.7822520507	26.82	30.96	20.2	7127	25.0864359	DE
156	-34.86	-59.5693779904	58.52	59.34	20.2	4540	26.82360877	DE
260	-155.29	-86.778429729	178.95	189.3	20.2	2610	28.33921574	DE

GXE - Frequently Asked Questions (FAQ)

What is the current Galapagos share price?

The current share price of Galapagos is 23,66 €

How many Galapagos shares are in issue?

Galapagos has 65.835.511 shares in issue

What is the market cap of Galapagos?

The market capitalisation of Galapagos is EUR 1,52B

What is the 1 year trading range for Galapagos share price?

Galapagos has traded in the range of 20,20 € to 30,96 € during the past year

What is the PE ratio of Galapagos?

The price to earnings ratio of Galapagos is 20,79

What is the cash to sales ratio of Galapagos?

The cash to sales ratio of Galapagos is 3,76

What is the reporting currency for Galapagos?

Galapagos reports financial results in EUR

What is the latest annual turnover for Galapagos?

The latest annual turnover of Galapagos is EUR 410,12M

What is the latest annual profit for Galapagos?

The latest annual profit of Galapagos is EUR 74,08M

What is the registered address of Galapagos?

The registered address for Galapagos is GENERAAL DE WITTELAAN L11, MECHELEN, ANTWERP, A3 2800

What is the Galapagos website address?

The website address for Galapagos is www.glpg.com

Which industry sector does Galapagos operate in?

Galapagos operates in the COML PHYSICAL, BIOLOGCL RESH sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
WW6Ww International Inc	0,3468 € (169,88%)	144,1k
OYM1Odyssey Marine Exploration Inc	1,39 € (82,89%)	120,38k
VW5Cannabist Company Holdings Inc	0,0643 € (78,61%)	153,41k
Z620Trillion Energy International Inc	0,0307 € (48,31%)	103,45k
K8DWellfield Technologies Inc	0,0142 € (47,92%)	500
A07Avance Gas Holding Ltd	0,27 € (-46,80%)	1,26M
3SHShunfeng International Clean Energy Limited	0,0014 € (-36,36%)	3k
SQRSaia Inc.	216,00 € (-30,77%)	528
L7C2Windfall Geotek Inc	0,008 € (-30,43%)	32,29k
3PJ1Golden Dory Resourses	0,02 € (-25,93%)	40k
DMLSayona Mining Limited	0,0113 € (4,63%)	2,52M
11LCanopy Growth Corporation	1,222 € (-6,86%)	2,31M
PF8European Lithium Limited	0,0314 € (3,29%)	2,18M
D7GNel ASA	0,1982 € (-1,49%)	2,15M
3CPXiaomi Corporation	5,459 € (-1,83%)	1,56M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Galapagos (GXE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Galapagos

GXE Neueste Nachrichten

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Announces Executive Leadership Updates

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

Galapagos to Present at Upcoming Investor Conferences

Galapagos receives transparency notification and 13D filing from Tang Capital

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

GXE - Frequently Asked Questions (FAQ)

Beweger

GXE Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Galapagos (GXE) Börsenkurse

Galapagos (GXE)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Galapagos

GXE Neueste Nachrichten

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Announces Executive Leadership Updates

Galapagos Announces Departure of Thad Huston, CFO and COO, as of August 1, 2025

Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders’ Meeting

Galapagos to Present at Upcoming Investor Conferences

Galapagos receives transparency notification and 13D filing from Tang Capital

Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update

Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities

Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma

GXE - Frequently Asked Questions (FAQ)

Beweger

GXE Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich für ein Konto unter ADVFN

Werbung entfernen